Results 221 to 230 of about 20,692 (311)

Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas

, 2020
I. Lazaridou, C Ram-Wolff, Jérôme Bouaziz, É. Bégon, Maxime Battistella, Jacqueline Rivet, M. Jachiet, M. Bagot, Annie Masson   +8 more
openalex   +2 more sources

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab [PDF]

, 2020
Sean Igelman, Chanho Na, Eric L. Simpson
openalex   +1 more source

Atopic dermatitis in the French cohort CONSTANCES (PreDDA study): Focus on persistence and remission in adulthood

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Khaled Ezzedine, Virginie Hourblin, Sophie Connétable, Fabrice Ruiz, Abdlekrim Ziad, Amélie Sobczak, Sofiane Kab, Adeline Renuy, Marcel Goldberg, Marie Zins, Audrey Nosbaum   +10 more
wiley   +1 more source

Cost‐utility analysis of sequential therapies for pediatric‐onset eosinophilic esophagitis

Journal of Pediatric Gastroenterology and Nutrition, Volume 81, Issue 2, Page 295-303, August 2025.
Abstract Objectives Topical corticosteroids, proton‐pump inhibitors (PPI) and elimination diets (ED) are equally recommended as first‐line therapies for pediatric eosinophilic esophagitis (EoE). Dupilumab (DUP) is usually used for refractoriness. We aim to assess the cost‐utility of all potential sequential treatments for EoE.
José Vicente Arcos‐Machancoses, Elena Crehuá‐Gaudiza, Cecilia Martínez‐Costa   +2 more
wiley   +1 more source

Successful Treatment of Hailey-Hailey Disease With Dupilumab. [PDF]

Cureus
Breimann J, Agarwala SN, Waseh S, Hsu S.
europepmc   +1 more source

Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial [PDF]

, 2020
Joseph F. Merola, Robert Sidbury, Andreas Wollenberg, Zhen Chen, Annie Zhang, Brad Shumel, Ana B. Rossi   +6 more
openalex   +1 more source

Cannabinoids and the Endocannabinoid System in the Treatment of Chronic Rhinosinusitis

The Laryngoscope, Volume 135, Issue 8, Page 2683-2690, August 2025.
The objective of this scoping review is to explore the role of the ECS in the pathophysiology of CRS. We identified five studies, all supporting a common conclusion that the ECS is implicated in regulating cellular inflammatory pathways potentially involved in sinonasal disease.
John J. W. Lee, Amr F. Hamour, Jacob G. J. Wihlidal, John M. Lee, Eric Monteiro, Ewa Poduch, Lakshmi Kotra, Allan D. Vescan   +7 more
wiley   +1 more source

Comparative Efficacy and Safety of Tralokinumab and Dupilumab in Moderate-to-Severe Atopic Dermatitis: A Narrative Review. [PDF]

J Clin Med
Kim YS.
europepmc   +1 more source

Case of bladder cancer during Dupilumab therapy: Just an incidental event?

, 2020
Niccolò Siliquini, Riccardo Viola, Maria Teresa Giura, Maria Teresa Fierro, Simone Ribero, Michela Ortoncelli   +5 more
openalex   +1 more source

Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report [PDF]

, 2020
Laine Ludriksone, Peter Elsner, Christina Malessa, Utz Settmacher, Sibylle Schliemann   +4 more
openalex   +1 more source